Compugen (CGEN) Current Assets (2009 - 2026)
Compugen's (CGEN) quarterly Current Assets came in at $137.3 million in Q1 2026, up 28.43% year-on-year from $106.9 million in Q1 2025, and down 7.25% quarter-over-quarter from $148.0 million in Q4 2025.
Compugen (CGEN) Current Assets (2009 - 2026) Analysis & Trends
Compugen has disclosed Current Assets across 18 years of filings, most recently posting $137.3 million for Q1 2026.
- Current Assets for Q1 2026 came in at $137.3 million, up 28.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $137.3 million (up 28.43% YoY), and the FY2025 annual result was $148.0 million, up 39.65% from the prior year.
- Current Assets came in at $137.3 million for Q1 2026 at Compugen, down from $148.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $148.0 million in Q4 2025 to a low of $60.3 million in Q3 2023.
- The 5-year median for Current Assets is $102.1 million (2024), against an average of $101.1 million.
- Across the five-year window, Current Assets sank 33.8% in 2023 and soared 90.52% in 2024, its largest moves.
- Compugen's Current Assets stood at $86.1 million in 2022, then surged by 33.04% to $114.6 million in 2023, then dropped by 7.49% to $106.0 million in 2024, then jumped by 39.65% to $148.0 million in 2025, then slipped by 7.25% to $137.3 million in 2026.
- The last three Current Assets figures came in at $137.3 million (Q1 2026), $148.0 million (Q4 2025), and $88.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 137.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137.28 Mn |
| Dec 31, 2025 | 148.02 Mn |
| Sep 30, 2025 | 88.92 Mn |
| Jun 30, 2025 | 97.64 Mn |
| Mar 31, 2025 | 106.89 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 114.83 Mn |
| Jun 30, 2024 | 102.13 Mn |
| Mar 31, 2024 | 105.57 Mn |
| Dec 31, 2023 | 114.58 Mn |
| Sep 30, 2023 | 60.27 Mn |
| Jun 30, 2023 | 69.40 Mn |
| Mar 31, 2023 | 76.44 Mn |
| Dec 31, 2022 | 86.13 Mn |
| Sep 30, 2022 | 91.04 Mn |
| Jun 30, 2022 | 101.98 Mn |
| Mar 31, 2022 | 112.12 Mn |
| Dec 31, 2021 | 123.22 Mn |
| Sep 30, 2021 | 112.28 Mn |
| Jun 30, 2021 | 113.75 Mn |